Use in Pregnancy: Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of foetal damage. The safety benzydamine hydrochloride has not been established in pregnant patients. Risk to benefit ratio should be established if Difflam is to be used in these patients.